Global Breast Biopsy Market: Research & Forecast 2018-2023 - Opportunities Arise from the Introduction of New Technologies Such as Vacuum Assisted Biopsy - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Nov 30, 2018--The “Global Breast Biopsy Market Research and Forecast 2018-2023” report has been added to ResearchAndMarkets.com’s offering.
Key factors contributing to the growth of the global breast biopsy market include high prevalence of breast cancer, increasing breast cancer screening programs, rising adoption of minimal invasive breast biopsies and high expenditure on breast cancer research.
High cost of procedure, risk and harmful effects of breast biopsy are restraining the market. Introduction of new technologies such as vacuum assisted biopsy and rising awareness among women are some opportunity for the market.
The global breast biopsy market is segmented on the basis of type, device and end user. Based on the type, the market is segmented into fine needle biopsy, core needle biopsy, surgical biopsy and others (lymph node and vacuum assisted biopsy. Surgical biopsy is further segmented into incisional and excisional. The core needle biopsy has the significant market during the forecast year and the vacuum assisted biopsy has the significant growth during the forecast year.
The device market is segmented into biopsy needles, guidance systems, biopsy tables and localization wires. The end user segment is bifurcated into hospitals, diagnostic centre and research institute.
North America holds a dominant position in the global breast biopsy market, followed by Europe. This is mainly due to high prevalence of breast cancer, rising adoption of minimal invasive breast biopsies significantly contributing towards the market growth in the region. The Asia pacific region is projected to exhibit the fastest growth in the global breast biopsy market over the forecast period. This is due to increasing breast cancer screening programs.
Some of the key players operating in the global breast biopsy market are Hologic, Becton, Dickinson & Company, F. Hoffmann-La Roche, Leica Biosystems and others. In order to sustain in the competitive market, these players adopt various strategies such as Acquisitions, mergers, expansions, joint ventures and product development for the growth of the market.
DriversHigh Prevalence of Breast Cancer Increasing Breast Cancer Screening Programs Rising Adoption of Minimal Invasive Breast Biopsies High Expenditure on Breast Cancer Research
RestraintsHigh Cost of Procedure Risk and Harmful Effects of Breast Biopsy
OpportunityIntroduction of New Technologies Such as Vacuum Assisted Biopsy
Key Topics Covered
Chapter 1. Report Summary
Chapter 2. Market Overview & Insights
Chapter 3. Market Determinant
Chapter 4. Market Segmentation
Chapter 5. Competitive Landscape
Chapter 6. Regional Analysis
Chapter 7. Company ProfilesArgon Medical Becton Dickinson & Company Benetec Medical Systems C. R. Bard Inc. Cianna Medical Cigna Cook Medical F. Hoffmann-La Roche Ltd. Hologic Inc. IMS Giotto S.P.A. Leica Biosystems Nussloch GmbH (Devicor Medical Products Inc.) Medtronic Noras MRI Products Oncocyte Corporation Planmed Oy Scion Medical Technologies LLC Somatex Medical Technologies GmbH Trivitron Healthcare United Medical Systems Inc. Vigeo Healthcare Solutions
For more information about this report visit https://www.researchandmarkets.com/research/l684px/global_breast?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181130005353/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Medical Devices
INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 11/30/2018 11:49 AM/DISC: 11/30/2018 11:49 AM